Safety and Efficacy of Deferasirox in Patients With Transfusion Dependent Iron Overload - a Non-comparative Extension Study

NCT01033747 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

70

Enrollment

INDUSTRY

Sponsor class

Conditions

Liver Iron Overload

Interventions

DRUG: Deferasirox
DRUG: Deferasirox

Sponsor

Novartis Pharmaceuticals